Espinel, Eugenia <br/><br/>
Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study.  [electronic resource] 

 -  BMC research notes  Aug 2013 
 - 306 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1756-0500 
<br/><br/><label>Standard No.: </label>10.1186/1756-0500-6-306  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin Receptor Antagonists--therapeutic use<br/>Angiotensin-Converting Enzyme Inhibitors--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Hyperkalemia--etiology<br/>Kidney Failure, Chronic--complications<br/>Male<br/>Middle Aged